Unither supports innovation that will benefit patients. It is in this perspective that we have been collaborating with CNRS, Paris Descartes University and AP-HP since 2012 on Sol-Gel technology.

The Sol-Gel technology is about in situ gel-forming formulations, which undergo phase transition from liquid to gel upon exposure to physiological environments. This technology combines advantages of being convenient for administration to patients and prolonging drug delivery.

So far, 6 international scientific publications dedicated to Sol-Gel technology have been published. You will find below the list of manuscripts that have been published so far. If you are interested in receiving the full version please send an email with your request to: unither@unither-pharmaceuticals.com

2014Influence of additives on a thermosensitive hydrogel for buccal deliveryof salbutamol: Relation Between micellization, gelation, mechanic and release properties
2015Poloxamer bioadhesive hydrogel for buccal drug delivery: Cytotoxicity and trans
epithelial permeability evaluations using TR146 human buccal epithelial cell line
2016In vitro and in vivo evaluation of in situ gelling systems for sustained topical ophthalmic delivery: state of the art and beyond
2017Cyanine derivative as a suitable marker for thermosensitive in situ gelling delivery systems: In vitro and in vivo validation of a sustained buccal drug delivery
2019Novel in situ gelling ophthalmic drug delivery system based on gellan gum and hydroxyethylcellulose: Innovative rheological characterization, in vitro and in vivo evidence of a sustained precorneal retention time
2020In Situ Gelling Ophthalmic Drug Delivery System for the Optimization of Diagnostic and Preoperative Mydriasis: In Vitro Drug Release, Cytotoxicity and Mydriasis Pharmacodynamics